Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary
FGFR2 和 MEK 抑制剂在治疗原发灶不明的 FGFR2 扩增癌症中的协同作用
期刊:Molecular Therapy
影响因子:12.1
doi:10.1016/j.ymthe.2024.07.011
Andrea Cavazzoni, Irene Salamon, Claudia Fumarola, Giulia Gallerani, Noemi Laprovitera, Francesco Gelsomino, Mattia Riefolo, Karim Rihawi, Elisa Porcellini, Tania Rossi, Martina Mazzeschi, Maria Naddeo, Salvatore Serravalle, Elisabetta Broseghini, Federico Agostinis, Olivier Deas, Roberta Roncarati,